Prospective, Non-Randomized Evaluation of Carbon Dioxide Gas as a Contrast Agent in Comparison With Iodinated Contrast in Endovascular Aneurysm Repair
1 other identifier
observational
N/A
1 country
1
Brief Summary
Endovascular repair of infrarenal abdominal aortic aneurysms (AAA) requires a contrast agent to identify the vascular anatomy and placement of the stent graft. Iodine contrast has traditionally been used, but has the potential to harm the kidneys. Another contrast agent is carbon dioxide gas. It has been proven safe to use, but the quality of the images it creates needs to be compared to iodine contrast. Patients in this study undergo the endovascular AAA repair as they normally, with the iodine contrast. At the end of surgery carbon dioxide gas contrast is given as an extra step. The images will be later evaluated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Oct 2006
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2006
CompletedFirst Submitted
Initial submission to the registry
August 22, 2007
CompletedFirst Posted
Study publicly available on registry
August 24, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
July 20, 2008
CompletedMarch 17, 2017
March 1, 2017
August 22, 2007
March 15, 2017
Conditions
Study Arms (1)
1
There is no control or experimental group. The same patients undergoing endovascular AAA repair with serve as their own control
Interventions
Eligibility Criteria
You may qualify if:
- Infrarenal abdominal aortic aneurysm amendable to endovascular repair
You may not qualify if:
- renal failure or contraindication to receiving iodine contrast.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
USC University Hospital
Los Angeles, California, 90033, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Fred A Weaver, MD
University of Southern California
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 22, 2007
First Posted
August 24, 2007
Study Start
October 1, 2006
Study Completion
July 20, 2008
Last Updated
March 17, 2017
Record last verified: 2017-03